DK1121127T3 - Orale farmaceutiske sammensætninger, som indeholder buprenorphin - Google Patents

Orale farmaceutiske sammensætninger, som indeholder buprenorphin

Info

Publication number
DK1121127T3
DK1121127T3 DK99950690T DK99950690T DK1121127T3 DK 1121127 T3 DK1121127 T3 DK 1121127T3 DK 99950690 T DK99950690 T DK 99950690T DK 99950690 T DK99950690 T DK 99950690T DK 1121127 T3 DK1121127 T3 DK 1121127T3
Authority
DK
Denmark
Prior art keywords
oral pharmaceutical
pharmaceutical compositions
compositions containing
containing buprenorphine
pharmaceutically acceptable
Prior art date
Application number
DK99950690T
Other languages
English (en)
Inventor
Mauro Valenti
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Application granted granted Critical
Publication of DK1121127T3 publication Critical patent/DK1121127T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
DK99950690T 1998-10-16 1999-10-11 Orale farmaceutiske sammensætninger, som indeholder buprenorphin DK1121127T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina
PCT/EP1999/007595 WO2000023079A1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
EP99950690A EP1121127B1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin

Publications (1)

Publication Number Publication Date
DK1121127T3 true DK1121127T3 (da) 2005-05-02

Family

ID=11380880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99950690T DK1121127T3 (da) 1998-10-16 1999-10-11 Orale farmaceutiske sammensætninger, som indeholder buprenorphin

Country Status (15)

Country Link
US (1) US6365596B1 (da)
EP (1) EP1121127B1 (da)
JP (1) JP2002527480A (da)
AT (1) ATE287264T1 (da)
AU (1) AU752449B2 (da)
CA (1) CA2347195C (da)
DE (1) DE69923336T2 (da)
DK (1) DK1121127T3 (da)
ES (1) ES2237165T3 (da)
HU (1) HU226166B1 (da)
IT (1) IT1302682B1 (da)
NZ (1) NZ511085A (da)
PT (1) PT1121127E (da)
SI (1) SI1121127T1 (da)
WO (1) WO2000023079A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1368023T3 (da) * 2001-02-16 2006-02-13 Gruenenthal Chemie Anvendelse af buprenoprphin til behandling af urininkontinens
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
WO2006097793A2 (en) 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
DE602004017514D1 (de) * 2004-06-02 2008-12-11 Galephar M F Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
RU2008124805A (ru) * 2005-11-21 2009-12-27 Шеринг-Плоу Лтд. (CH) Фармацевтические композиции, содержащие бупренорфин
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
US20090082383A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched buprenorphine
CA2963659C (en) 2008-09-17 2020-06-23 Chiasma Inc. Use of oral octreotride compositions
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
US20130071477A1 (en) 2011-09-19 2013-03-21 Orexo Ab New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
DK3043777T3 (da) 2013-09-10 2020-07-20 Fresh Cut Dev Llc Sublingual buprenorphinspray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016007245A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
EP3253401A4 (en) 2015-02-03 2018-11-21 Chiasma Inc. Method of treating diseases
JP2021511326A (ja) 2018-01-22 2021-05-06 フォアシー ファーマシューティカルズ シーオー．，リミテッド ブプレノルフィンの徐放送達のための薬学的組成物
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605671A (en) 1984-09-28 1986-08-12 American Home Products Corporation Parenteral formulation
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JPH08295637A (ja) * 1995-04-27 1996-11-12 Green Cross Corp:The 口腔部局所投与剤
DE69709646T2 (de) * 1996-03-12 2002-08-14 Alza Corp Zusammensetzung und dosisform mit einem opioid-antagonisten
JP3687025B2 (ja) * 1998-06-04 2005-08-24 東和薬品株式会社 安定なマレイン酸エナラプリル錠剤

Also Published As

Publication number Publication date
SI1121127T1 (en) 2005-06-30
ITMI982222A0 (it) 1998-10-16
AU752449B2 (en) 2002-09-19
US6365596B1 (en) 2002-04-02
PT1121127E (pt) 2005-03-31
CA2347195A1 (en) 2000-04-27
ATE287264T1 (de) 2005-02-15
WO2000023079A1 (en) 2000-04-27
JP2002527480A (ja) 2002-08-27
HU226166B1 (en) 2008-05-28
EP1121127A1 (en) 2001-08-08
AU6337199A (en) 2000-05-08
IT1302682B1 (it) 2000-09-29
ES2237165T3 (es) 2005-07-16
DE69923336D1 (de) 2005-02-24
DE69923336T2 (de) 2005-05-25
EP1121127B1 (en) 2005-01-19
ITMI982222A1 (it) 2000-04-16
HUP0103924A3 (en) 2003-05-28
HUP0103924A2 (hu) 2002-02-28
NZ511085A (en) 2002-10-25
CA2347195C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
NO20034149D0 (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
AU7102201A (en) Propane-1,3-dione derivatives
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE122008000001I1 (de) Orale Dosiszusammensetzungen mit verlängerter Freigabe
ATE356625T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung enthaltend 5,8,14- triazatetracyclo (10.3.1.0(2,11) 0 (4,9) )- hexadeca-2(11) 3, 5,7, 9-pentaene
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
HUP0102676A3 (en) Solid, quick dissolving pharmaceutical compositions containing cetrizine
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
CA2366679A1 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
WO2006072070A3 (en) Pharmaceutical formulations of gallium salts
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
EP1142573A4 (en) ANTIBACTERIAL MEDICAL COMPILATION
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2003061572A8 (en) Anti-inflammatory formulations
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use